Champignon Brands (CSE: SHRM- OTC: SHRMF) CEO Dr Roger McIntyre joined Steve Darling from Proactive Vancouver to discuss his new role with the company that is pursuing the development and commercialization of rapid onset treatments of depression and post-traumatic stress disorders using medicinal mushroom-infused products.
Dr McIntyre talks about his role for the company and also about their recent 10 million dollar financing and where he sees that money being utilized.
Price: 0.89 CAD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Champignon Brands Inc. named herein, including the promotion by the Company of Champignon Brands Inc. in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE
Champignon Brands (CSE: SHRM- OTCQB: SHRMF) CEO Dr Roger McIntyre joined Steve Darling from Proactive Vancouver with news the company is changing its name to Apotheosis, which means the high point of development. McIntyre discusses the thinking behind the change, plus acquisitions and other...
Prev article
